Guangzhou, China

Chuiliang Yu

This inventor holds 1 USPTO granted patent. Top assignees: Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd., Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuiliang Yu. Retrieved from https://idiyas.com/inventor/chuiliang-yu-hsgycmug

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chuiliang Yu and His Pharmaceutical Innovation

Introduction

Chuiliang Yu is an inventor associated with Guangzhou, China. His work includes a pharmaceutical composition developed for potential use in preventing or treating cataracts.

Latest Patents

Yu is credited with 1 patent: “Pharmaceutical Composition, Preparation Method Therefor and Application Thereof.” The invention describes a composition containing a compound represented by Formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. It also outlines a preparation method and the composition’s potential application in medicines for preventing or treating cataracts.

The patent describes the composition as having stability under light exposure and high temperatures, allowing room-temperature storage. It is designed to have pH and osmotic pressure close to those of the intraocular environment, with a uniform particle-size distribution intended to support patient comfort and convenient use.

Career Highlights

Yu has been associated with Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. His patent reflects work in ophthalmic pharmaceutical development, particularly in formulations intended for cataract prevention or treatment.

Collaborations

Yandong Wang and Yingxue Su are identified as Yu’s coworkers, reflecting professional connections within his ophthalmic pharmaceutical work.

Conclusion

Chuiliang Yu’s patent focuses on a stable, patient-oriented ophthalmic pharmaceutical composition with potential application in cataract prevention or treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…